Xencor (XNCR) News Today $23.07 -0.43 (-1.83%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Insider Selling: Xencor, Inc. (NASDAQ:XNCR) CEO Sells 3,366 Shares of StockNovember 15 at 11:30 AM | insidertrades.comInsider Selling: Xencor, Inc. (NASDAQ:XNCR) VP Sells 68,684 Shares of StockNovember 14 at 8:01 AM | insidertrades.comXencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14%November 13, 2024 | finance.yahoo.comLeerink Partnrs Issues Positive Outlook for Xencor EarningsNovember 13, 2024 | americanbankingnews.comWedbush Estimates Xencor's FY2024 Earnings (NASDAQ:XNCR)November 11, 2024 | americanbankingnews.comLeerink Partnrs Increases Earnings Estimates for XencorXencor, Inc. (NASDAQ:XNCR - Free Report) - Leerink Partnrs upped their FY2024 earnings per share estimates for shares of Xencor in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst J. Chang now forecasts that the biopharmaceutical company will poNovember 11, 2024 | marketbeat.comWhat is Wedbush's Forecast for Xencor FY2024 Earnings?Xencor, Inc. (NASDAQ:XNCR - Free Report) - Stock analysts at Wedbush increased their FY2024 EPS estimates for Xencor in a research report issued on Thursday, November 7th. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company will earn ($3.64) per share for the year, up fNovember 11, 2024 | marketbeat.comXencor (NASDAQ:XNCR) Given "Outperform" Rating at BMO Capital MarketsNovember 10, 2024 | americanbankingnews.comXencor (NASDAQ:XNCR) Price Target Raised to $28.00November 10, 2024 | americanbankingnews.comBMO Capital Markets Reaffirms "Outperform" Rating for Xencor (NASDAQ:XNCR)BMO Capital Markets reissued an "outperform" rating and issued a $34.00 price objective (up previously from $32.00) on shares of Xencor in a research report on Friday.November 8, 2024 | marketbeat.comBarclays Sticks to Its Sell Rating for Xencor (XNCR)November 8, 2024 | markets.businessinsider.comXencor’s Promising Oncology and Immunology Pipeline Drives Buy RatingNovember 8, 2024 | markets.businessinsider.comXencor (XNCR) Receives a Buy from RBC CapitalNovember 8, 2024 | markets.businessinsider.comXencor’s Promising Advancements and Strategic Developments Justify Buy RatingNovember 7, 2024 | markets.businessinsider.comXencor’s Strategic Advancements and Promising Pipeline Drive Buy RatingNovember 7, 2024 | markets.businessinsider.comXencor (NASDAQ:XNCR) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysJPMorgan Chase & Co. boosted their price target on Xencor from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Thursday.November 7, 2024 | marketbeat.comXencor Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | businesswire.comXencor doses first subject in first-in-human study of XmAb942November 5, 2024 | markets.businessinsider.comXencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by AnalystsShares of Xencor, Inc. (NASDAQ:XNCR - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nine brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and oneOctober 26, 2024 | marketbeat.comEssex LLC Takes Position in Xencor, Inc. (NASDAQ:XNCR)Essex LLC bought a new position in Xencor, Inc. (NASDAQ:XNCR - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 132,661 shares of the biopharmaceutical company's stock, valued at approximately $2,668,000. Essex LLC owned about 0October 20, 2024 | marketbeat.comState Street Corp's Strategic Reduction in Xencor Inc HoldingsOctober 19, 2024 | finance.yahoo.comAQR Capital Management LLC Makes New Investment in Xencor, Inc. (NASDAQ:XNCR)AQR Capital Management LLC acquired a new stake in Xencor, Inc. (NASDAQ:XNCR - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 39,791 shares of the biopharmaceutical company's stock, valued at approximately $753,000. AQR Capital MaOctober 14, 2024 | marketbeat.comXencor (NASDAQ:XNCR) Stock Quotes, Forecast and News SummaryOctober 8, 2024 | benzinga.comXencor Announces Upcoming Change to Board of DirectorsOctober 4, 2024 | businesswire.comDimensional Fund Advisors LP Has $27.63 Million Stock Holdings in Xencor, Inc. (NASDAQ:XNCR)Dimensional Fund Advisors LP increased its position in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 6.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,459,427 shares of the biopharmaceutical company's stOctober 3, 2024 | marketbeat.comCubist Systematic Strategies LLC Reduces Holdings in Xencor, Inc. (NASDAQ:XNCR)Cubist Systematic Strategies LLC decreased its position in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 47.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 101,653 shares of the biopharmaceutical company's stock after selling 91October 1, 2024 | marketbeat.comXencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Buy" from AnalystsShares of Xencor, Inc. (NASDAQ:XNCR - Get Free Report) have been given an average rating of "Buy" by the nine brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has assiOctober 1, 2024 | marketbeat.comShort Interest in Xencor, Inc. (NASDAQ:XNCR) Increases By 24.8%Xencor, Inc. (NASDAQ:XNCR - Get Free Report) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 5,830,000 shares, an increase of 24.8% from the August 31st total of 4,670,000 shares. Based on an average daily trading volume, of 530,700 shares, the days-to-cover ratio is currently 11.0 days.September 28, 2024 | marketbeat.comPoint72 Asset Management L.P. Increases Stock Position in Xencor, Inc. (NASDAQ:XNCR)Point72 Asset Management L.P. raised its position in Xencor, Inc. (NASDAQ:XNCR - Free Report) by 52.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,261,789 shares of the biopharmaceutical company's stock after acquiSeptember 27, 2024 | marketbeat.comXencor Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)September 27, 2024 | benzinga.comXencor (XNCR) Gets a Buy from RBC CapitalSeptember 27, 2024 | markets.businessinsider.comXencor (NASDAQ:XNCR) Price Target Raised to $34.00Royal Bank of Canada raised their target price on shares of Xencor from $31.00 to $34.00 and gave the stock an "outperform" rating in a report on Thursday.September 26, 2024 | marketbeat.comArmistice Capital LLC Sells 136,000 Shares of Xencor, Inc. (NASDAQ:XNCR)Armistice Capital LLC lowered its stake in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 13.6% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 864,000 shares of the biopharmaceutical company's stock after selling 136,000 shares during the period.September 26, 2024 | marketbeat.comLogos Global Management LP Purchases 850,000 Shares of Xencor, Inc. (NASDAQ:XNCR)Logos Global Management LP grew its position in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 130.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,500,000 shares of the biopharmaceutical company's stock after acquiring an additional 850,000 sharesSeptember 24, 2024 | marketbeat.comXencor, Inc. (NASDAQ:XNCR) Shares Acquired by Primecap Management Co. CAPrimecap Management Co. CA increased its stake in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 0.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,116,202 shares of the biopharmaSeptember 17, 2024 | marketbeat.comXencor Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesSeptember 13, 2024 | tmcnet.comXencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesSeptember 12, 2024 | finance.yahoo.comXencor (NASDAQ:XNCR) Stock Price Down 4%Xencor (NASDAQ:XNCR) Stock Price Down 4%September 12, 2024 | marketbeat.comXencor: Vudalimab Development Along With Hidden Gem CandidateSeptember 12, 2024 | seekingalpha.comXencor Shares Climb on $175 Million OfferingSeptember 11, 2024 | marketwatch.comXencor’s Innovative Pipeline and Market Expansion Justify ‘Buy’ Rating and $38 Price TargetSeptember 11, 2024 | markets.businessinsider.comXencor Announces Proposed Public Offering of Common StockSeptember 11, 2024 | finance.yahoo.comXencor Announces Pricing of $175 Million Public Offering of Common StockSeptember 11, 2024 | finance.yahoo.comXencor Prices Public Offering Of 6.64 Mln Shares At $18/shrSeptember 11, 2024 | markets.businessinsider.comXencor (NASDAQ:XNCR) Sees Strong Trading VolumeXencor (NASDAQ:XNCR) Sees Large Volume IncreaseSeptember 11, 2024 | marketbeat.comXencor Up 26% on R&D Updates, Dose Escalation ResultsSeptember 10, 2024 | marketwatch.comXencor stock rallies 24% amid drug development updatesSeptember 10, 2024 | seekingalpha.comXencor's (XNCR) Outperform Rating Reaffirmed at WedbushWedbush reiterated an "outperform" rating and set a $34.00 price target on shares of Xencor in a research note on Monday.September 9, 2024 | marketbeat.comXencor (NASDAQ:XNCR) Shares Gap Up to $16.18Xencor (NASDAQ:XNCR) Shares Gap Up to $16.18September 9, 2024 | marketbeat.comCandriam S.C.A. Decreases Position in Xencor, Inc. (NASDAQ:XNCR)Candriam S.C.A. trimmed its holdings in shares of Xencor, Inc. (NASDAQ:XNCR - Free Report) by 52.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 310,019 shares of the biopharmaceutical company's stock afterSeptember 9, 2024 | marketbeat.com Get Xencor News Delivered to You Automatically Sign up to receive the latest news and ratings for XNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… XNCR Media Mentions By Week XNCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XNCR News Sentiment▼0.620.56▲Average Medical News Sentiment XNCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XNCR Articles This Week▼183▲XNCR Articles Average Week Get Xencor News Delivered to You Automatically Sign up to receive the latest news and ratings for XNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kura Oncology News Zymeworks News MacroGenics News Prelude Therapeutics News Cytokinetics News Blueprint Medicines News Lantheus News Nuvalent News Avidity Biosciences News Arcellx News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XNCR) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xencor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xencor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
